Coronavirus

 

Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (Abstract)

Eur Heart J Cardiovasc Pharmacother
18 February 2022
https://pubmed.ncbi.nlm.nih.gov/35179184/

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19

DocWire News Featured Reading
18 February 2022
https://www.docwirenews.com/abstracts/repurposing-low-dose-naltrexone-ldn-for-the-prevention-and-treatment-of-immunothrombosis-in-covid-19/